Some of the emerging therapies for the Opioid withdrawal syndrome treatment include CHF6563 (Chiesi Farmaceutici), APH-1501 (Aphios Corporation), Lofexidine (US WorldMeds), and several others. For more details visit https://www.delveinsight.com/blog/opioid-withdrawal-syndrome/ or refer to https://www.delveinsight.com/
